NCT06360406 2026-03-31Real-World Treatment Study of Koselugo (Selumetinib)AstraZenecaRecruiting200 enrolled
NCT05388370 2026-03-12PASS of Paediatric Patients Initiating SelumetinibAstraZenecaActive not recruiting124 enrolled